JESUS RODRIGUEZ: Open Payments
NPI 1396179255 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,655 in 138 payments from 29 companies in 2025. Trend: 2023 $3,363 · 2024 $2,594 · 2025 $2,655
Food & beverage: $2,595Education: $60
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 19 | $389 |
| Lilly USA, LLC | 23 | $341 |
| Novo Nordisk Inc | 21 | $325 |
| AstraZeneca Pharmaceuticals LP | 12 | $263 |
| PFIZER INC. | 13 | $196 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $180 |
| Corcept Therapeutics | 6 | $130 |
| Astellas Pharma US Inc | 3 | $120 |
| Abbott Laboratories | 4 | $81 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $67 |
Products named: MOUNJARO, Kerendia, OTEZLA, REPATHA, Ozempic, Korlym, JARDIANCE, FARXIGA.
Industry payments across FL — which companies pay providers there.
